EMILIN2 has been shown to suppress growth of cancer cells [16] and triggers apoptosis in cancer cells via the extrinsic apoptosis pathway following EMILIN2 binding to the trail receptors DR4 and DR5. This evidence concerns the gene TNFRSF10A and cancer.